What is Amfora?
Amfora is a San Francisco-based biotechnology company dedicated to advancing nutritional crop development. The company leverages cutting-edge scientific research to enhance the nutritional value of crops, aiming to address global food security and health challenges. Its focus on developing improved crop varieties positions it as a key player in the agricultural technology and life sciences industries.
How much funding has Amfora raised?
Amfora has raised a total of $12M across 2 funding rounds:
Series A
$5M
Series B
$7M
Series A (2017): $5M with participation from Spruce Capital and Commonwealth Scientific Industrial Research Organization (CSIRO)
Series B (2021): $7M led by BayWa, Spruce Capital Partners, and Leaps by Bayer
Key Investors in Amfora
Spruce Capital
Spruce Capital is an investment firm that has participated in Amfora's funding rounds, suggesting a focus on companies within Amfora's sector.
BayWa
BayWa, a diversified company with interests in agriculture, energy, and construction, brings a broad industrial perspective to its investment in Amfora, potentially offering strategic synergies.
Spruce Capital Partners
Spruce Capital Partners, a venture capital firm specializing in Ag, Nutrition, and Industrial Life Sciences, provides strategic investment and guidance to innovative companies like Amfora.
What's next for Amfora?
The recent major strategic investment signals a pivotal phase for Amfora, likely enabling the company to scale its operations, accelerate research and development, and expand its market reach. This capital infusion is expected to fuel further innovation in nutritional crop development, potentially leading to new product launches and strategic partnerships. Amfora's trajectory suggests a focus on translating its scientific advancements into tangible solutions for the agricultural sector and beyond.
See full Amfora company page
